Resverlogix Corp. (TSE:RVX – Get Free Report) shares reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as C$0.04 and last traded at C$0.05, with a volume of 3000 shares changing hands. The stock had previously closed at C$0.04.
Resverlogix Stock Up 12.5 %
The company has a market capitalization of C$8.91 million, a price-to-earnings ratio of -2.23 and a beta of 0.71. The company has a debt-to-equity ratio of -10.95, a quick ratio of 0.04 and a current ratio of 0.13. The business’s 50 day moving average is C$0.05 and its 200 day moving average is C$0.06.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Articles
- Five stocks we like better than Resverlogix
- Why Are Stock Sectors Important to Successful Investing?
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Earnings Per Share Calculator: How to Calculate EPS
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Using the MarketBeat Stock Split Calculator
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
